Get the content you want anytime you want.

A Review of Transdermal Vaccine Delivery

According to the World Health Organization, vaccine development and mass immunization strategies remain critical initiatives, especially because of the continued threat of pandemics of diseases such as H1N1 swine influenza, as well as emerging diseases such as Ebola virus disease.
In a recent review article in Biomedicine and Pharmacotherapy, Kevin Ita, PhD, from Touro University, Mare Island-Vallejo, California, discusses some techniques used for enhancing vaccine delivery, highlighting the progress made in their development, as well as some challenges that these techniques continue to pose to scientists.
Although many vaccines are administered as injections, this delivery route is associated with disadvantages such as pain, needle stick injuries, needle-phobia, and poor patient compliance.
The transdermal route therefore offers an opportunity to improve vaccine administration. And, because it targets the skin’s potent immune cell populations, it may lead to a strong immune response at much lower doses than would be needed using an injectable vaccine.
“Two layers of the human skin—epidermis and dermis—are populated by dendritic cells (DCs), which are potent antigen-presenting cells (APCs),” the author writes. “Transcutaneous immunization has therefore become an attractive and alternative route for vaccination.”
Techniques such as sonophoresis, microneedle-assisted delivery, iontophoresis, and elastic liposomes are among those being used and developed for transdermal vaccine delivery.


Sonophoresis is a technique that uses ultrasound to permeabilize the stratum corneum layer of the skin. When ultrasound travels through a coupling fluid, it produces cavitation bubbles. These bubbles oscillate and increase in size over many cycles of the pressure wave. The main mechanism for sonophoresis-enhanced permeability of the skin is particular inertial cavitation, whereby cavitation bubbles can implode when they are close to a liquid–solid interface, generating an intense local shockwave. This produces a jet of liquid that can penetrate the stratum corneum. And, because the cavitation effect inversely correlates with ultrasound frequency, this technique is efficient for permeabilization of the skin.
Sonophoresis has been described for administration of tetanus toxoid in mice and hepatitis B surface antigen in pigs, generating an effective immune response in both cases.
However, this technique may cause burning of the skin in some cases, and epidermal necrosis may occur at high intensities. 

Microneedle-assisted delivery

According to the author, “[m]icroneedles (MN) are needles with lengths in the micrometer range (typically less than 1000 micrometers) which create pores in the skin and enable medications or vaccines to be delivered locally or transdermally into systemic circulation”.
MNs can be categorized as hollow, solid, coated, dissolving, or hydrogel-forming. They are advantageous because their use does not require professional training. The technique is also painless, minimally invasive, minimally traumatic, bloodless, and avoids contaminating the bloodstream with pathogens.
The use of MNs has been applied to DNA vaccines to help resolve the problem of their poor immunogenicity. MN delivery is considered to enhance the immunogenicity of DNA vaccine-encoded antigens to the skin, and animal studies using this technique have shown that an effective immune response can be generated to hepatitis B virus and influenza virus. The technique has also been used in animals to deliver immunotherapeutic peptides to vaccinate against ovarian cancer.
Transdermal delivery using MNs has also been used to administer polio vaccine to volunteers. It has also been used to investigate delivery of the bacillus Calmette-Guérin (BCG) vaccine and the tetanus toxoid in animal models.
However, it can be challenging to deliver high doses of medications using MNs, the author says. In addition, matrix retention of some polymeric MNs in the skin can also lead to low patient compliance. 

Want more information on this topic and the opportunity to ask questions of an expert? Register for a live, ACPE accredited webinar February 28th 8-9 PM EST at this link:
Big advances in treatment can